Jiang Xinxin Medtec Co (SZSE:300453) Cash And Cash Equivalents : ¥178 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Jiang Xinxin Medtec Co Cash And Cash Equivalents?

Jiang Xinxin Medtec Co's quarterly cash and cash equivalents increased from Sep. 2024 (¥121.82 Mil) to Dec. 2024 (¥289.85 Mil) but then stayed the same from Dec. 2024 (¥289.85 Mil) to Mar. 2025 (¥177.72 Mil).

Jiang Xinxin Medtec Co's annual cash and cash equivalents declined from Dec. 2022 (¥320.33 Mil) to Dec. 2023 (¥221.29 Mil) but then increased from Dec. 2023 (¥221.29 Mil) to Dec. 2024 (¥289.85 Mil).

Jiang Xinxin Medtec Co Cash And Cash Equivalents Historical Data

The historical data trend for Jiang Xinxin Medtec Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiang Xinxin Medtec Co Cash And Cash Equivalents Chart

Jiang Xinxin Medtec Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash And Cash Equivalents

Get a 7-Day Free Trial

98.27

250.80

320.33

221.29

289.85

Jiang Xinxin Medtec Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash And Cash Equivalents	Get a 7-Day Free Trial															182.84	126.26	121.82	289.85	177.72

Jiang Xinxin Medtec Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Jiang Xinxin Medtec Co (SZSE:300453) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Jiang Xinxin Medtec Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Jiang Xinxin Medtec Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiang Xinxin Medtec Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jiang Xi Sanxin Medtec Co Ltd (SZSE:300453) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 999, Fushan Avenue, Xiaolan Economic Development Zone, Nanchang County, Jiangxi Province, Nanchang, CHN, 330200

Website

http://www.sanxin-med.com

Jiang Xi Sanxin Medtec Co Ltd is engaged in researching and developing, manufacturing and marketing of medical devices. Its products include four series: blood purification, indwelling catheters, injections, infusion and blood transfusion. Blood purification products are used in clinical dialysis treatment for uremic patients. Indwelling catheter products represented by venous indwelling needles, positive pressure indwelling needles, central venous catheters. Injectable products mainly include self-destructing syringes, retracting self-destructing syringes, conjoined syringes.

Executives

Zhang Lin	Supervisors
Le Zhen Rong	Executives
Mao Zhi Ping	Directors, executives
Yu Zhen Zhu	Supervisors
Peng Yi Xing	Director
Liu Ming	Securities Affairs Representative
Wan Xiao Ping	Director
Wang Qin Hua	Supervisors
Xiong Yan	Supervisors

Jiang Xinxin Medtec Co Headlines

No Headlines